On Tuesday, Wave Life Sciences Ltd (NASDAQ: WVE) opened higher 1.24% from the last session, before settling in for the closing price of $6.46. Price fluctuations for WVE have ranged from $4.25 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 607.85% over the past five years. Company’s average yearly earnings per share was noted -43.09% at the time writing. With a float of $123.09 million, this company’s outstanding shares have now reached $154.09 million.
Let’s look at the performance matrix of the company that is accounted for 288 employees. In terms of profitability, gross margin is 50.71%, operating margin of -119.83%, and the pretax margin is -107.04%.
Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Wave Life Sciences Ltd is 20.14%, while institutional ownership is 81.13%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -43.09% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -1.87% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Check out the current performance indicators for Wave Life Sciences Ltd (WVE). In the past quarter, the stock posted a quick ratio of 2.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.61.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.03 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 1.11 million, a negative change from its year-to-date volume of 1.28 million. As of the previous 9 days, the stock’s Stochastic %D was 52.60%. Additionally, its Average True Range was 0.54.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 14.58%, which indicates a significant decrease from 33.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 82.87% in the past 14 days, which was higher than the 76.64% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.53, while its 200-day Moving Average is $9.94. Nevertheless, the first resistance level for the watch stands at $6.65 in the near term. At $6.76, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.95. If the price goes on to break the first support level at $6.35, it is likely to go to the next support level at $6.16. The third support level lies at $6.05 if the price breaches the second support level.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
There are currently 154,134K shares outstanding in the company with a market cap of 1.01 billion. Presently, the company’s annual sales total 108,300 K according to its annual income of -97,010 K. Last quarter, the company’s sales amounted to 9,180 K and its income totaled -46,880 K.
